GENNEX LABORATORIES
Back to Cashflow Statement
|
GENNEX LABORATORIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-5.41 Cr | ₹46 Cr | ₹6.38 Cr | ₹7.61 Cr | ₹0.16 Cr |
What is the latest Net Cash Inflow / Outflow ratio of GENNEX LABORATORIES ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-5.41 Cr |
| Mar2024 | ₹46 Cr |
| Mar2023 | ₹6.38 Cr |
| Mar2022 | ₹7.61 Cr |
| Mar2021 | ₹0.16 Cr |
How is Net Cash Inflow / Outflow of GENNEX LABORATORIES Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-5.41 Cr | Negative | |
| Mar2024 | ₹46 Cr | 619.50 | |
| Mar2023 | ₹6.38 Cr | -16.16 | |
| Mar2022 | ₹7.61 Cr | 4,747.77 | |
| Mar2021 | ₹0.16 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of GENNEX LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENNEX LABORATORIES | ₹250.4 Cr | -0.1% | 20.6% | -20.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,859.0 Cr | 4.2% | 5.3% | 1.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,618.0 Cr | 3.4% | 12.6% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,718.0 Cr | 2.2% | 4.1% | 28% | Stock Analytics | |
| CIPLA | ₹107,722.0 Cr | 2% | 11.5% | -13.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,081.0 Cr | -6.2% | 5.1% | 9.5% | Stock Analytics | |
GENNEX LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENNEX LABORATORIES | -0.1% |
20.6% |
-20.8% |
| SENSEX | -0.4% |
7.1% |
-4% |
You may also like the below Video Courses